Order Article Reprints

Robella M, De Simone M, Berchialla P, Argenziano M, Borsano A, Ansari S, Abollino O, Ficiarà E, Cinquegrana A, Cavalli R, et al. A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis. Cancers. 2021; 13(5):1060. https://doi.org/10.3390/cancers13051060

Robella, Manuela, Michele De Simone, Paola Berchialla, Monica Argenziano, Alice Borsano, Shoeb Ansari, Ornella Abollino, Eleonora Ficiarà, Armando Cinquegrana, Roberta Cavalli, and et al. 2021. "A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis" Cancers 13, no. 5: 1060. https://doi.org/10.3390/cancers13051060

Robella, M., De Simone, M., Berchialla, P., Argenziano, M., Borsano, A., Ansari, S., Abollino, O., Ficiarà, E., Cinquegrana, A., Cavalli, R., & Vaira, M. (2021). A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis. Cancers, 13(5), 1060. https://doi.org/10.3390/cancers13051060